Allied Academies look forward to welcome all the participants across the globe to attend “21st World Congress and Exhibition on Vaccines, Vaccination & Immunization” which is going to be held during November 16-17, 2017 in Vienna, Austria. The conference highlights the theme “Advanced Technologies and Featured Challenges in Vaccine Research and Development” covering all important aspects in Vaccines and their therapeutic methods.
Vaccines World 2017 conference features highly enlightening & interactive sessions to encourage the exchange of ideas across world in the field of vaccination and their therapeutic methods. The conference includes keynote talks from distinguished scientists, plenary sessions, business delegates, Poster Presentations, Young Researcher forum sessions, Symposiums, Workshop and Exhibitions.
We all know Infectious disease threat events (IDTEs) are increasing in frequency worldwide. We analyzed underlying drivers of 116 IDTEs detected in Europe during 2008–2013 by epidemic intelligence at the European Centre of Disease Prevention and Control. These infectious diseases are majorly transmitted through food-borne, waterborne, vector-borne and rodent-borne in all over the world. Especially in the border of European countries. Nearly half of the 27 Infectious diseases are within the vector-borne and rodent-borne category was caused by West Nile virus (WNV) infections. Four of these Infectious disease consisted of WNV cases in 4 different European countries and 1 large outbreak in south-eastern Europe with more-than 260 cases. Measles and mumps are still endemic in many European countries due to the poor vaccination coverage among country populations, migrants and vaccine hesitancy. So, Specific vaccination strategies are often necessary for these populations to improve the immunization of children and adults from infectious diseases, spread of infection due to crowded living conditions. And ensure the continuity of childhood immunization schedules.
In order to accelerate the research in the field of Vaccination and Immunization Allied Academies organizes different conferences worldwide. American people focused on the industrial leaders and Medical professionals, Vaccine Research Development, Vaccine Business, Immunological Research, Vaccine Value Chain community, Immuno-informatics and Vaccine-Informatics. Vaccines Business tripled in value from $5 billion in 2000 to almost $24 billion in 2013, Vaccine Global market projected to raise up to $100 billion by 2025. UNICEY reached 1430 billion dollars in 2011 in the vaccines business as the global leader.
Why to attend???
21st World Congress and Exhibition on Vaccines, Vaccination and Immunization is a unique forum to bring together worldwide distinguished academics in the field of vaccinology and Immunology, Vaccine researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. With members from around the world focused on learning about vaccines and vaccination effects; this is your best opportunity to reach the largest assemblage of participants from the vaccine and Immunology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in vaccines and its research are hallmarks of this conference. Aim of this conference is stimulate new ideas to develop the research of vaccine that will be beneficial across the spectrum of many infectious and non-infectious diseases.
Target Audience:
Conferenc Highlights:
Novel Vaccines - Research and Development
Basic Vaccinology
Ebola outbreak
Vaccines discovery, development & formulation
Vaccine clinical trials
Vaccine Management & Quality Assurance
Vaccine Immunoinformatics
Therapeutic vaccination for auto immune diseases
Vaccination for Viral Diseases
Development of therapeuics for Viral diseases
Recombinant Viral Vaccine
Meningococcal conjugate vaccination for HIV patient
Chikungunya virus
Viral vaccine and Anti-viral drug
Adverse effects of viral vaccines
Immunisation schedule for viral diseases
Human Papilloma Virus Infection
Advances in HPV Vaccine
HPV Vaccines for Men
HPV Vaccine risks and controversies
HPV Vaccine for Women
Global HPV Vaccine Market Analysis
Cancer Immunotherapy
Feline Leukemia Vaccines
Cancer Vaccines research
Cancer Immunotherapy Biomarkers
Non-specific cancer immunotherapies and adjuvants
Oncolytic viral therapies
Gene-therapy
CAR T-Cell Therapy
Cancer treatment Vaccines
Cancer prevention Vaccines
Cervical Cancer Vaccine
Vaccination for Bacterial Diseases
Vaccine for enteric-bacterial infection
Respiratory bacterial vaccine
Bacterial vaccine failure in Children
Vaccine against fish-bacterial disease
Epidemiology of vaccine-preventable diseases
Immunisation schedule for bacterial diseases
Infants/Children Vaccines
Immunization for Children
Infant Immunization scheduling
Childhood Travel Immunization
Polio Vaccine
Hib Vaccine
Human Vaccines - Infectious & Non Infectious Diseases
Human Vaccines & Immunotherapeutics
DNA vaccines
Recombinant-vector vaccines
Zoster vaccine
Human papilloma vaccine
Conjugate vaccines
Vaccination for Pregnancy
Immunization before pregnancy
Whooping cough Vaccine in pregnant women
Immunization during pregnancy
Immunization after pregnancy
Consequences of halting vaccination in pregnancy
Chiropractic vaccination care in women and pregnancy
Vaccination for older/aged People
Need of vaccine for aged people
Vaccinatoin hand outs for older people
Shingles vaccine
Parkinson's diseases vaccine
Herpes roster vaccine
Veterinary Vaccines
Current status of veterinary vaccines
Vaccines for Livestock Diseases
Safety or efficacy of a veterinary medicine
Animal health outcomes
Recent Advances in Animal Vaccination
Plant-Based Vaccines
Productoin and Challenges in Plant based vaccine
Biotherapeutics of plant vaccine
Plant based vaccine against virus
Molecular level of plant based vaccine
Recombinant/Transenic plant based vaccine
Clinical Trials in Animals Models
Animal models
Anti-Tumor Response
Zika Virus phase I test
Immune Cells responsiveness
Ebola’s Immune Escape
Side Effects of Vaccines
Adverse effects of vaccines
Is vaccination leads to Autism?
HPV Vaccine safety and tolerability
Contraindication to vaccine use
Vaccine Design-Immunoinformatics
Web-based tool for vaccine design
Epitope vaccine design
Advances in the field of immunoinformatics
Challenges in immuno-informatics
Genomic and Proteomic way of approach
Advances in Vaccine and Drug delivery technologies
Next-Generation Adjuvants
Advances in DNA Vaccines, TLRS and Combination Adjuvants
Addressing Unmet Vaccine Needs
Adjuvant Safety Issues
Adjuvant Regulatory Requirements
Viral vectors as vaccne carrier
Novel Marker Vaccine
Vaccines and Adjuvants Mechanisms of Action
Vaccine Quality Control
Vaccination for Vector-borne Diseases
Zika Virus
Malaria
Dengue
Chikungunya
Yellow fever
Lyme disease
Japanese encephalitis
Leishmaniasis
Vaccines for Neurodegenerative Disorder
Neurology of Alzheimer’s and Parkinson's
Vaccine against Alzheimer’s
Gene-based vaccines
Immunotherapeutic strategies
Public Health Issues in Vaccines
Vaccination for International Traveller
Travel Acquired Infectious Diseases
Allergies and Skin Diseases
Vaccine Choice for Immune-Compromised Travel
Vaccines Practice During Travel
Vaccine: Travel Health Software
Digital Healthcare about Vaccines
Health Considerations for Adventure Travel
Nov 16
2017
Nov 17
2017
Draft paper submission deadline
Registration deadline
Submit Comment